NBCA DVT/PE Awareness Survey Results – Oncology
Survey Demonstrates DVT/PE Awareness is Low Among Cancer Patients and Prophylaxis is Underutilized
Despite being at increased risk for deep vein thrombosis (DVT) and pulmonary embolism (PE), most cancer patients are not aware of the terms DVT and PE. Compared to oncology inpatients, DVT/PE prophylaxis is utilized much less frequently among oncology outpatients, according to NBCA’s DVT/PE Awareness Survey data.
Awareness Data from Cancer Patients
Data from the survey show that, among the 500 cancer patients surveyed, less than one-quarter (24%) are aware of the term DVT, and only 15% are aware of the term PE. When oncology inpatient responses are compared to those of oncology outpatients, the survey findings demonstrate that significantly more inpatients are aware of DVT and PE: Just 15% (p=<.05%) of oncology outpatients surveyed are aware of the term DVT, compared to 36% of inpatients; and, just 9% (p=<.05%) of outpatients are aware of the term PE, compared to 24% of inpatients surveyed. Similarly, significantly fewer outpatients (14%, p=<.05%), when compared to inpatients (44%), say that their doctor or another healthcare professional informed them about the risk of developing blood clots due to cancer.
The NBCA DVT/PE Awareness Survey was made possible by a grant from Ortho-McNeil™, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.